Cold & Cough Remedies - Belgium | Statista Market Forecast

In Belgium, the revenue generated in the Cold & Cough Remedies market market in 2024 amounts to US$210.20m.
According to projections, the market is expected to experience an annual growth rate of 4.41% (CAGR 2024-2029).
When compared to other countries worldwide, the United States generates the highest revenue in this market, reaching US$11.19bn in 2024.
In terms of per capita figures, the revenue generated per person in Belgium amounts to US$17.94 in 2024.
Belgium's cold and cough remedies market is seeing a surge in demand for natural and herbal products.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies market in Belgium has been experiencing steady growth in recent years.

Customer preferences: Belgian consumers have shown a strong preference for over-the-counter cold and cough remedies. They value convenience and accessibility, and prefer to treat their symptoms at home rather than visit a doctor. This has led to an increase in the demand for over-the-counter remedies that are easily available in pharmacies and supermarkets.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Belgium is the growing demand for natural and herbal remedies. Belgian consumers are becoming more conscious of the ingredients in the products they use and are seeking alternatives to traditional pharmaceutical remedies. This trend is in line with the global shift towards natural and organic products. Manufacturers have responded to this trend by introducing a wide range of natural and herbal remedies to the market.Another trend in the market is the increasing popularity of combination products. These are remedies that offer relief for multiple cold and cough symptoms in a single product. Combination products are convenient for consumers as they eliminate the need to purchase multiple remedies for different symptoms. This trend is driven by the desire for simplicity and convenience among Belgian consumers.

Local special circumstances: Belgium has a well-developed healthcare system with a high level of accessibility to healthcare services. This has contributed to the preference for over-the-counter remedies as consumers are able to easily access these products without a prescription. Additionally, the country has a high level of health consciousness and a strong emphasis on self-care, which further drives the demand for over-the-counter remedies.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in Belgium can also be attributed to several macroeconomic factors. The country has a stable economy with a high standard of living, which allows consumers to spend more on healthcare products. Furthermore, the aging population in Belgium is driving the demand for cold and cough remedies as older individuals are more susceptible to respiratory illnesses. The increasing prevalence of respiratory conditions such as asthma and allergies is also contributing to the growth of the market.In conclusion, the Cold & Cough Remedies market in Belgium is experiencing steady growth due to the preference for over-the-counter remedies, the demand for natural and herbal products, and the increasing popularity of combination products. The well-developed healthcare system, high level of health consciousness, and stable economy in Belgium are all contributing factors to the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.